Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.

The price of Vaxcyte Inc (NASDAQ: PCVX) closed at $32.72 in the last session, up 0.96% from day before closing price of $32.41. In other words, the price has increased by $0.96 from its previous closing price. On the day, 1.11 million shares were traded. PCVX stock price reached its highest trading level at $32.72 during the session, while it also had its lowest trading level at $31.75.

Ratios:

We take a closer look at PCVX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 11.11 and its Current Ratio is at 11.11. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.

On December 20, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $135. On December 07, 2023, Mizuho started tracking the stock assigning a Buy rating and target price of $69.Mizuho initiated its Buy rating on December 07, 2023, with a $69 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 05 ’25 when Eydelman Mikhail sold 5,000 shares for $70.74 per share. The transaction valued at 353,699 led to the insider holds 41,620 shares of the business.

Eydelman Mikhail bought 5,000 shares of PCVX for $344,350 on Mar 05 ’25. On Mar 03 ’25, another insider, Wassil Jim, who serves as the CHIEF OPERATING OFFICER of the company, sold 8,000 shares for $73.27 each. As a result, the insider received 586,165 and left with 154,931 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PCVX now has a Market Capitalization of 4247808768 and an Enterprise Value of 2672238080.

Stock Price History:

The Beta on a monthly basis for PCVX is 1.09, which has changed by -0.71184504 over the last 52 weeks, in comparison to a change of 0.1725707 over the same period for the S&P500. Over the past 52 weeks, PCVX has reached a high of $121.06, while it has fallen to a 52-week low of $27.66. The 50-Day Moving Average of the stock is -1.56%, while the 200-Day Moving Average is calculated to be -40.67%.

Shares Statistics:

According to the various share statistics, PCVX traded on average about 1.43M shares per day over the past 3-months and 1531330 shares per day over the past 10 days. A total of 129.82M shares are outstanding, with a floating share count of 125.36M. Insiders hold about 3.44% of the company’s shares, while institutions hold 111.77% stake in the company. Shares short for PCVX as of 1755216000 were 11435242 with a Short Ratio of 7.99, compared to 1752537600 on 13618625. Therefore, it implies a Short% of Shares Outstanding of 11435242 and a Short% of Float of 9.86.

Earnings Estimates

Investors are keenly observing as 5.0 analysts analyze and rate the current performance of Vaxcyte Inc (PCVX) in the stock market.The consensus estimate for the next quarter is -$1.36, with high estimates of -$1.05 and low estimates of -$1.71.

Analysts are recommending an EPS of between -$4.34 and -$5.96 for the fiscal current year, implying an average EPS of -$5.1. EPS for the following year is -$5.97, with 5.0 analysts recommending between -$4.16 and -$7.28.